Status:
COMPLETED
Two Implementation Strategies for the Collection of Electronic Patient-Reported Outcomes Among Patients With Multiple Myeloma
Lead Sponsor:
Thomas Jefferson University
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial evaluates satisfaction and engagement with a text messaging platform (TXT-Chatbot) compared to a patient portal system (MyChart/Patient Portal) for reporting symptoms among patient...
Detailed Description
PRIMARY OBJECTIVES: I. To evaluate the patients' preference of TXT-Chatbot approach versus MyChart/Patient Portal approach, considering their demographic information. II. To evaluate each patient's ...
Eligibility Criteria
Inclusion
- Diagnosis of MM
- Able to use TXT or have Internet access
- Can read and understand English
- If patients are undergoing an autologous stem cell transplant, they will be enrolled after their transplant
Exclusion
- \< 18 years of age
- Cognitive impairment documented in the electronic medical record (EMR)
Key Trial Info
Start Date :
June 13 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 17 2025
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT06041698
Start Date
June 13 2023
End Date
January 17 2025
Last Update
July 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107